Mr Doug Roeder

KANDO id: 88042

Bio

Doug joined Delphi Ventures as an Associate in 1998 and became a Partner in 2000. His primary investment focus at Delphi is on medical devices and diagnostics. Doug currently serves on the boards of EBR Systems, Ivantis, Senseonics Holdings, and Tandem Diabetes Care. He previously served on the boards of Evalve (acquired by Abbott) and TriVascular (acquired by Endologix). Prior to joining Delphi, Doug was an Associate with Alex. Brown's Healthcare Investment Banking Group in San Francisco. While at Alex. Brown Doug assisted in the execution of over a dozen financing and merger transactions involving both Fortune 500 and venture-backed medical technology companies, including a number of Delphi portfolio companies. Previously, Doug was with Putnam Associates, a consulting firm focused on the biopharmaceutical industry, where his primary role was to develop and implement a strategy for the launch of a leading biotech drug.

Career


Delphi Ventures Inc

Venture capital firm with a focus on early stage investing in medical devices and biotechnology

Education